Details for New Drug Application (NDA): 050703
✉ Email this page to a colleague
The generic ingredient in BACTROBAN is mupirocin. There are sixteen drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the mupirocin profile page.
Summary for 050703
Tradename: | BACTROBAN |
Applicant: | Glaxosmithkline |
Ingredient: | mupirocin calcium |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;NASAL | Strength | EQ 2% BASE | ||||
Approval Date: | Sep 18, 1995 | TE: | RLD: | Yes |
Expired US Patents for NDA 050703
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Glaxosmithkline | BACTROBAN | mupirocin calcium | OINTMENT;NASAL | 050703-001 | Sep 18, 1995 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription